?? THE SNAKE ANTIVENOM OF THE FUTURE.
An article
in the October issue Science described a new drug that could save the lives of
up to 100,000 Africans. It’s 3 years
away from trials in humans but if it works—who knows.
The article
claims that each year about 100,000 Africans are killed by venomous snakes and
the current antivenom isn’t very effective for a number of reasons.
“This new
kind of antivenom has proved protective only in mice so far. But “It’s a potential game changer if all goes
well.”
To make
their antivenum Laustsen-Kiel and colleagues injected mixtures of venoms from
18 African snakes into llamas and alpacas and the animals made antibodies.
Their
antibodies are smaller than those of horses and humans and have only one
protein chain, instead of two, on each arm of the Y-shaped molecule.
Each arm,
dubbed a nanobody, can be separated from its base while remaining able to bind
a target molecule, such as a toxin.
The
isolated arms lack the animal-specific sections that set off allergic
reactions.
The team
took the DNA sequences for the llama and alpaca nanobodies and added them
to Escherichia coli bacterial cells to mass produce them in
vitro. Then they screened for the ones that most effectively inactivated the
toxins of the 18 snakes, including 13 species of cobras, four species of mamba,
and one rinkhal.
AND
ultimately identified eight nanobodies that, injected together with lethal
doses of the venoms of the 18 snakes, protected mice from all but one snake--
the eastern green mamba (Dendroaspis angusticeps). When the mice were injected first with the
venom and received the cocktail 5 minutes later, it protected them from eight
of 11 snake species tested. Laustsen-Kiel says the group now plans to
investigate adding more effective nanobodies for the toxins of the three
remaining snakes. Interesting.
Comments
Post a Comment